BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36814284)

  • 21. Enhancing nasopharyngeal carcinoma cell radiosensitivity by suppressing AKT/mTOR via CENP-N knockdown.
    Wu LZ; Zou Y; Wang BR; Ni HF; Kong YG; Hua QQ; Chen SM
    J Transl Med; 2023 Nov; 21(1):792. PubMed ID: 37940975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the expression of SNHG1 and its effect on the PI3K-AKT axis in nasopharyngeal cancer.
    Yang Y; Yang YP; Yi ML; Huang FT; Zhu X; Huang GW
    Neoplasma; 2023 Oct; 70(5):670-682. PubMed ID: 38053377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-372 enhances radiosensitivity while inhibiting cell invasion and metastasis in nasopharyngeal carcinoma through activating the PBK-dependent p53 signaling pathway.
    Wang Z; Mao JW; Liu GY; Wang FG; Ju ZS; Zhou D; Wang RY
    Cancer Med; 2019 Feb; 8(2):712-728. PubMed ID: 30656832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA PTPRG-AS1/microRNA-124-3p regulates radiosensitivity of nasopharyngeal carcinoma via the LIM Homeobox 2-dependent Notch pathway through competitive endogenous RNA mechanism.
    Shen Z; Wu Y; He G
    Bioengineered; 2022 Apr; 13(4):8208-8225. PubMed ID: 35300558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokeratin 13 promotes radiotherapy sensitivity of nasopharyngeal carcinoma by downregulating the MEK/ERK pathway.
    Shi M; Wan J; Wang H; Yu H
    IUBMB Life; 2022 Jun; 74(6):543-553. PubMed ID: 35426961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
    Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
    Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Dicer1 targeted by EBV-miR-BART6-5p on biological properties and radiosensitivity of nasopharyngeal carcinoma.
    Tang J; Liu ZY; Tang Y; Wang Y
    Hum Exp Toxicol; 2021 Jun; 40(6):977-993. PubMed ID: 33305599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell Proliferation and Apoptosis-Related Genes Affect the Development of Human Nasopharyngeal Carcinoma Through PI3K/AKT Signaling Pathway.
    Li W; Ma H; Liu M
    Mol Biotechnol; 2021 Nov; 63(11):1081-1091. PubMed ID: 34236626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acylglycerol kinase promotes the stemness of nasopharyngeal carcinoma cells by promoting β-catenin translocation to the nucleus through activating PI3K/Akt pathway.
    Zhao Q; Sun P; Qin S; Liu J
    Environ Toxicol; 2020 Dec; 35(12):1299-1307. PubMed ID: 32652857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
    Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
    Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-142 promotes the development of nasopharyngeal carcinoma through targeting PTEN.
    Li DP; Chai W; Liu YH; Xu TT; Huang H
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3806-3812. PubMed ID: 31115007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B; Gu Q; Li J
    Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing of lncRNA MIR31HG promotes nasopharyngeal carcinoma cell proliferation and inhibits apoptosis through suppressing the PI3K/AKT signaling pathway.
    Feng B; Chen K; Zhang W; Zheng Q; He Y
    J Clin Lab Anal; 2022 Dec; 36(12):e24720. PubMed ID: 36347827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of NOX4 on radiosensitivity of nasopharyngeal carcinoma cells by activating the PI3K/AKT pathway].
    Ning XH; Liu J; Hu L; Lu HY; Liu Q; Wang DH
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 May; 55(5):514-519. PubMed ID: 32842368
    [No Abstract]   [Full Text] [Related]  

  • 36. Capn4 regulates Snail to promote the epithelial-mesenchymal transition of nasopharyngeal carcinoma by mediating the transcriptional activity of claudin-11.
    Yang F; Wang F; Gao ZS; Quang GQ; Hu HB; Zheng M
    Kaohsiung J Med Sci; 2023 Feb; 39(2):134-144. PubMed ID: 36354184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chitinase 3 like-1 activates the Akt pathway, inducing NF-κB-dependent release of pro-inflammatory cytokines and promoting the proliferative ability in nasopharyngeal carcinoma cells.
    Li D; Fan G; Zhou Y
    Cytokine; 2024 Jul; 179():156631. PubMed ID: 38710115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma.
    Zhen Y; Liu Z; Yang H; Yu X; Wu Q; Hua S; Long X; Jiang Q; Song Y; Cheng C; Wang H; Zhao M; Fu Q; Lyu X; Chen Y; Fan Y; Liu Y; Li X; Fang W
    Cell Death Dis; 2013 Oct; 4(10):e872. PubMed ID: 24157866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma.
    Jiang C; Cheng Z; Jiang T; Xu Y; Wang B
    Genes Genomics; 2020 Aug; 42(8):971-978. PubMed ID: 32648233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinoma.
    Zhao L; Tang M; Hu Z; Yan B; Pi W; Li Z; Zhang J; Zhang L; Jiang W; Li G; Qiu Y; Hu F; Liu F; Lu J; Chen X; Xiao L; Xu Z; Tao Y; Yang L; Bode AM; Dong Z; Zhou J; Fan J; Sun L; Cao Y
    Oncotarget; 2015 Jun; 6(18):15995-6018. PubMed ID: 26201446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.